Tandem Diabetes' Funding Rounds
Tandem Diabetes has raised a total of $101M over 6 funding rounds: 3 Late-Stage, 1 Debt and 2 Post IPO rounds. Tandem Diabetes' largest funding round so far was a Post IPO round for $***** in May 2020.
Here is the list of all funding rounds of Tandem Diabetes:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 15, 2020 | 5388192 | Post IPO | 8591682 | 3315118 | 6124299 | 7394110 |
Jan 16, 2018 | 6300142 | Post IPO | 4224375 | 9711916 | 5323159 | 2746157 |
Jan 12, 2016 | 4260769 | Conventional Debt | 9982206 | 5219442 | 5301263 | |
Sep 10, 2012 | 3303408 | Series D | 1914411 | 8560139 | 1678109 | 8810295 |
Aug 18, 2011 | 3994893 | Series C | 4367065 | 3932377 | 5092568 | 6369847 |
Jan 07, 2010 | 4941863 | 964005 | 9135134 | 2997671 | 1421548 | 3604585 |
Access funding benchmarks and valuations. Sign up today!
Sign up to download Tandem Diabetes' company profile
Tandem Diabetes' Investors
Tandem Diabetes has total 7 investors, 7 are institutional investors including Gynther Capital and 6 others.
Here is the list of institutional investors of Tandem Diabetes:
- CRG, located in Houston (United States), made their first investment in Tandem Diabetes on Jan 12, 2016 in its Conventional Debt round.
Are you a Founder ?
FAQs about Tandem Diabetes' funding and investors
Explore latest companies that raised funding recently
- Bionessmedical - raised a funding of $15M in Conventional Debt round held on Sep 04, 2026.
- Octave - raised a funding of $11.6M in Series A round held on Sep 04, 2026.
- Octave - raised a funding in Conventional Debt round held on Sep 04, 2026.
- Creoir - raised a funding in Seed round held on Sep 04, 2026.
- DivergeIT - raised a funding in Seed round held on Sep 04, 2026.
